BEAM
Price
$24.95
Change
+$0.28 (+1.13%)
Updated
Sep 18 closing price
Capitalization
2.58B
50 days until earnings call
Intraday BUY SELL Signals
GNOM
Price
$66.40
Change
-$0.52 (-0.78%)
Updated
Sep 18 closing price
Net Assets
100.59M
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs GNOM

BEAM vs GNOM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BEAM vs. GNOM commentary
Sep 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and GNOM is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMGNOM
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
90%
COMPARISON
Comparison
Sep 21, 2026
Stock price -- (BEAM: $24.95)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green while .

  • BEAM’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish.

  • BEAM’s TA Score: 5 bullish, 6 bearish.

Price Growth

BEAM (@Biotechnology) experienced а +4.00% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.53%. For the same industry, the average monthly price growth was -8.46%, and the average quarterly price growth was +7.13%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (+1.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BEAM
Daily Signal:
Gain/Loss:
GNOM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPBC49.910.34
+0.69%
Simplify US Equity PLUS Bitcoin Strategy ETF (SPBC)
IBND30.450.05
+0.16%
State Street SPDR Bloomberg International Corporate Bond ETF (IBND)
JABS49.510.02
+0.04%
Janus Henderson Asset-Backed Securities ETF (JABS)
TFJL18.64N/A
N/A
Innovator 20 Year Treasury Bond 5 Floor ETF
FNCL79.11-0.30
-0.38%
Fidelity MSCI Financials Index ETF (FNCL)

GNOM and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNOM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if GNOM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNOM
1D Price
Change %
GNOM100%
-0.78%
CRSP - GNOM
70%
Closely correlated
-1.33%
MRNA - GNOM
69%
Closely correlated
-2.55%
BEAM - GNOM
61%
Loosely correlated
+1.13%
NTRA - GNOM
60%
Loosely correlated
+0.84%
PACB - GNOM
60%
Loosely correlated
-0.72%
More